Opus Genetics, Inc. (IRD) SEC Filings & Financial Intelligence
Opus Genetics, Inc. (IRD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IRD
CIK: 1228627
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerWilliam Love
Audit LocationDetroit, Michigan, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-05 | 2026-11-03 | FORM 4 | 0001140361-26-042102 | View SEC Doc Filr Page |
| 144 | 2026-11-03 | — | 144 Filing | 0001974078-26-000396 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-27 | — | SCHEDULE 13G Filing | 0002012383-26-003823 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001140361-26-040908 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001140361-26-040906 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001140361-26-040896 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-23 | FORM 4 | 0001140361-26-040893 | View SEC Doc Filr Page |
| 144 | 2026-10-23 | — | 144 Filing | 0001974078-26-000387 | View SEC Doc Filr Page |
| 144 | 2026-10-23 | — | 144 Filing | 0001974158-26-000110 | View SEC Doc Filr Page |
| 144 | 2026-10-23 | — | 144 Filing | 0001974078-26-000385 | View SEC Doc Filr Page |
| 8-K | 2026-10-21 | 2026-10-19 | 8-K | 0001140361-26-040377 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-14 | 8-K | 0001140361-26-039781 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0002042266-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | FORM 4 | 0001140361-26-036347 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-11 | 8-K | 0001140361-26-036277 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001140361-26-035979 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | FORM 4 | 0001140361-26-035913 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | FORM 4 | 0001140361-26-035912 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001974158-26-000100 | View SEC Doc Filr Page |
| EFFECT | 2026-08-14 | — | EFFECT Filing | 9999999995-26-002668 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352641 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001727492-26-000020 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003425 | View SEC Doc Filr Page |
| CORRESP | 2026-08-13 | — | CORRESP Filing | 0001140361-26-032692 | View SEC Doc Filr Page |
| UPLOAD | 2026-08-12 | — | UPLOAD Filing | 0000000000-26-007928 | View SEC Doc Filr Page |